AC
BLUE

Armistice Capital’s bluebird bio BLUE Stock Holding History

Armistice Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-117,400
Closed -$23.5M – 146
2021
Q4 		$23.5M Sell
117,400
-73,438
-38% -$17.3M 0.38% 54
2021
Q3 		$47.2M Buy
190,838
+49,099
+35% +$14M 0.8% 30
2021
Q2 		$58.7M Sell
141,739
-9,882
-7% -$3.91M 1.05% 21
2021
Q1 		$59.2M Buy
151,621
+83,839
+124% +$41.3M 1.36% 18
2020
Q4 		$38M Buy
67,782
+6,022
+10% +$3.82M 1.29% 22
2020
Q3 		$43.2M Buy
61,760
+17,910
+41% +$14M 1.57% 18
2020
Q2 		$34.7M Sell
43,850
-6,176
-12% -$4.66M 1.52% 21
2020
Q1 		$29.8M Buy
50,026
+24,087
+93% +$23.5M 1.84% 17
2019
Q4 		$29.5M Buy
+25,939
New +$28.2M 1.7% 15
2019
Q3 		– Sell
-7,720
Closed -$12.7M – 67
2019
Q2 		$12.7M Buy
7,720
+2,470
+47% +$4.27M 0.8% 33
2019
Q1 		$10.7M Buy
+5,250
New +$9.24M 0.59% 39
2018
Q4 		– Sell
-6,794
Closed -$12.8M – 73
2018
Q3 		$12.8M Sell
6,794
-7,102
-51% -$14.7M 0.77% 38
2018
Q2 		$28.3M Buy
13,896
+9,264
+200% +$21.1M 1.84% 21
2018
Q1 		$10.2M Buy
4,632
+1,930
+71% +$4.91M 0.78% 41
2017
Q4 		$6.23M Sell
2,702
-232
-8% -$471K 0.62% 43
2017
Q3 		$5.22M Buy
2,934
+772
+36% +$1.08M 0.61% 48
2017
Q2 		$2.94M Buy
2,162
+309
+17% +$373K 0.37% 52
2017
Q1 		$2.18M Sell
1,853
-1,235
-40% -$1.26M 0.45% 41
2016
Q4 		$2.47M Buy
+3,088
New +$2.45M 0.58% 42
2016
Q3 		– Sell
-7,411
Closed -$4.16M – 45
2016
Q2 		$4.16M Buy
+7,411
New +$4.2M 1.58% 27

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Armistice Capital's BLUE Position: Q1 2022 in Review

Armistice Capital sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 117,400 shares — an estimated $23.5M sold.

Armistice Capital first reported a position in BLUE in Q2 2016 and held it in 20 quarters. The position peaked at $59.2M in Q1 2021. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

  • Armistice Capital reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
  • Armistice Capital sold 117,400 bluebird bio shares in Q1 2022, an estimated $23.5M.
  • Armistice Capital first reported a position in bluebird bio in Q2 2016 and held it in 20 quarters.
  • Armistice Capital's bluebird bio position peaked at $59.2M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.